AC
RDY icon

AXQ Capital’s Dr. Reddy's Laboratories RDY Stock Holding History

AXQ Capital’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,325
Closed -$283K – 677
2024
Q1 		$283K Buy
+19,325
New +$282K 0.07% 442
2023
Q3 		– Sell
-30,430
Closed -$384K – 572
2023
Q2 		$384K Buy
+30,430
New +$355K 0.47% 70

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AXQ Capital's RDY Position: Q2 2024 in Review

AXQ Capital sold out of Dr. Reddy's Laboratories (RDY) in Q2 2024, closing a stake of 19,325 shares — an estimated $283K sold.

AXQ Capital first reported a position in RDY in Q2 2023 and held it in 2 quarters. The position peaked at $384K in Q2 2023. 222 funds tracked by Wall St. Rank hold RDY as of Q2 2024.

  • AXQ Capital reported no remaining Dr. Reddy's Laboratories position as of Q2 2024 after selling out during the quarter.
  • AXQ Capital sold 19,325 Dr. Reddy's Laboratories shares in Q2 2024, an estimated $283K.
  • AXQ Capital first reported a position in Dr. Reddy's Laboratories in Q2 2023 and held it in 2 quarters.
  • AXQ Capital's Dr. Reddy's Laboratories position peaked at $384K in Q2 2023.
  • 222 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2024.

Based on AXQ Capital's 13F filing for Q2 2024, filed 13 Aug 2024.